Hvivo Plc (HVO) Ord 0.1p
0.35p
(5.00%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.35p
(5.00%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.35p
(5.00%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
7.00p
7.78p
21.10p
£50.51 million
7.00p
6.80p
4.35p
4.14
0.45p (6.87%) Previous:
0.45p
9,326,908
2.72%
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue (£m) | 62.73 | 56.04 |
| Profit before tax (£m) | 13.29 | 11.15 |
| Adjusted EPS (p): | 1.69 | 1.27 |
| P/E ratio | 12.10 | 18.70 |
| PEG | 0.40 | 0.60 |
| EPS growth (%) | 33.00 | 32.00 |
Values are quoted in the stock's local currency: British pound
All fundamental dataRecent dividends paid or declared by Hvivo Plc:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| Final | 15/05/2025 | 11/06/2025 | 0.20p |
| Final | 18/04/2024 | 20/05/2024 | 0.20p |
| Special | 04/05/2023 | 09/06/2023 | 0.45p |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual Hvivo Plc dividends:
| Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
|---|---|---|---|
| 31/12/2024 | 1.00% | 8.45 | 0.20p |
| 31/12/2023 | 0.80% | 6.35 | 0.20p |
| 31/12/2022 | 4.50% | 2.13 | 0.45p |
| 31/12/2021 | n/a | n/a | n/a |
| 31/12/2020 | n/a | n/a | n/a |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyReady to invest?
Important Documents
There are no documents available for this stock.
-
Shore Capital hails improved US biotech funding environment for hVIVO
12 December 2025 12:52
-
Hvivo client acquired by MSD in $9.2bn deal
27 November 2025 07:58
-
hVivo reports positive results from its largest lab contract to date
30 June 2025 09:29
-
Appointment of Non-Executive Director
18 December 2025 07:00
-
CEO & CFO Share Purchase
15 December 2025 14:47
-
MSD to acquire Cidara
27 November 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.